AstraZeneca boss spies opportunities from Trump and Brexit

To many, Trump’s victory and Britain’s decision to leave the European Union is not something to be overly happy about, however the chief executive of parmacutacal giant AstraZeneca has made a statement claiming that Brexit and the US election outcome could create opportunities for the company. Ketan Patel, fund manager at EdenTree agrees, discussing with The Telegraph why he remains optimistic on AstraZeneca following the release of their ‘weak’ Q3 results.